BusinessAtlas Technology International to Present at Upcoming Investor ConferencesBy Nasdaq OMXSep 1, 2017, 2:31 PM UTC
BusinessImmune Therapeutics, Inc. Appoints John H. Abeles, M.D. as Chairman and CEO of Company’s Subsidiary, Cytocom, Inc. and as Senior Adviser to Immune Therapeutics, Inc.By Nasdaq OMXAug 23, 2017, 1:04 PM UTC
BusinessAtlas Technology International Sees Record Fourth Fiscal QuarterBy Nasdaq OMXAug 21, 2017, 1:07 PM UTC
BusinessGreengro Technologies, Inc. Retains Investor Relations Partners to Support Company’s Strategic IR ProgramBy Nasdaq OMXMay 25, 2017, 5:35 PM UTC
BusinessGreengro Technologies, Inc. Retains Investor Relations Partners to Support Company’s Strategic IR ProgramBy Nasdaq OMXMay 25, 2017, 5:35 PM UTC
BusinessAtlas Technology International Expects to Exceed Previously Announced Third Quarter Revenue Guidance; Company to Announce Third Quarter and Nine Month Results on Monday, May 15, 2017By Nasdaq OMXMay 10, 2017, 4:18 PM UTC
BusinessAtlas Technology International Retains Investor Relations Partners to Support Company’s Strategic IR ProgramBy Nasdaq OMXFeb 2, 2017, 3:34 PM UTC
BusinessBang Holdings Provides Positive Year-End Business Update and Guidance; Company on Schedule to Monetize its Digital Media NetworkBy Nasdaq OMXDec 20, 2016, 2:06 PM UTC
